Showing results (111-120 of 192) with videos related to

Sort By:
Pageof 20
Federation Proceedings|April 1, 1984
CI-906 and CI-907: new orally active nonsulfhydryl angiotensin-converting enzyme inhibitorsH R Kaplan, D M Cohen, A D Essenburg, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 26, 2001
Hematological effects in F344 rats and B6C3F1 mice during the 13-week gavage toxicity study of methylene blue trihydrateM R Hejtmancik, M J Ryan, J D Toft, et al.
Medical and Pediatric Oncology|January 1, 1978
CCNU, vinblastine, and delalutin therapy in renal cell carcinomaG J Vosika, M J Ryan, I A Fortuny, et al.
Biopharmaceutics & Drug Disposition|May 7, 1998
Pharmacokinetics and pharmacodynamics of CI-992 following intravenous and oral administration to cynomolgus monkeysJ A Cook, P J Burger, B M Michniewicz, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1993
Disparity between blood pressure and PRA inhibition after administration of a renin inhibitor to anesthetized dogs: methodological considerationsR K Palmer, S T Rapundalo, B L Batley, et al.
Kidney International|June 26, 2001
Risk factors and mortality associated with calciphylaxis in end-stage renal diseaseA R Mazhar, R J Johnson, D Gillen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1994
Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeysM J Ryan, G W Hicks, B L Batley, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 7, 2002
Comparative gavage subchronic toxicity studies of o-chloroaniline and m-chloroaniline in F344 rats and B6C3F1 miceM R Hejtmancik, B A Trela, P J Kurtz, et al.
Pageof 20